Valuation survey for SF-6Dv2 in Japan based on the international protocol [PDF]
Purpose: The SF-6D Classification System was recently updated (SF-6Dv2). We performed a valuation survey to construct a value set for the SF-6Dv2 in Japan. Methods: An online discrete choice experiment (DCE) with duration was used to estimate a value
Bjorner, J. +8 more
core +7 more sources
Creating an SF-6Dv2 social value set for New Zealand [PDF]
The SF-6D health descriptive system and its second version published in 2020, the SF-6Dv2, is used worldwide for valuing health-related quality of life (HRQoL) for economic evaluation and measuring patient-reported health outcomes.
Trudy Sullivan +2 more
exaly +4 more sources
Health utility scores of six common cancers in China measured by SF-6Dv2 [PDF]
Purpose Given the recent update of SF-6Dv2, detailed data on utility scores for cancer patients by cancer type remain scarce in China and other regions, which limits the precision of cost-utility analyses (CUA) in cancer interventions.
Yuchun Tao +7 more
doaj +4 more sources
Valuing SF-6Dv2 Using a Discrete Choice Experiment in a General Population in Quebec, Canada [PDF]
Background An updated version of the Short-Form 6-Dimension (SF-6D) Classification System has been developed. This new version (SF-6Dv2) with improved consistency and dimension descriptors is now requiring the development of new utility value sets.
Hosein Ameri, Thomas G. Poder
doaj +4 more sources
Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese patients with type 2 diabetes mellitus [PDF]
Objective The Audit of Diabetes-Dependent Quality of Life (ADDQoL) is a widely used instrument for assessing quality of life in Type 2 Diabetes Mellitus (T2DM). However, it does not directly yield health utility values essential for economic evaluations.
Haoran Fang +5 more
doaj +4 more sources
A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population [PDF]
This paper describes the first evaluation of the construct validity and performance of the newly developed preference-based measure of health, the SF-6D version 2 (SF-6Dv2).Utilising data from the Multi-Instrument Comparison (MIC) project (n = 7932), we explored the descriptive differences in utility values between the SF-6Dv2 and the SF-6D and ...
Emily McDool +2 more
exaly +7 more sources
Valuation of SF-6Dv2 health states in China using time trade-off and discrete-choice experiment with a duration dimension [PDF]
Objectives Our objective was to generate a value set for the SF-6Dv2 using time trade-off (TTO) and a discrete-choice experiment with a duration dimension (DCETTO) in China.
Bai, G. +11 more
core +3 more sources
Assessment of health-related quality of life of patients with gout and hyperuricemia in the Tianjin area according to the SF-6Dv2 scale [PDF]
BackgroundThe number of patients with hyperuricemia and gout is constantly rising and the conditions are seriously affecting their quality of life. Thus, it is of great importance to identify a assessment scale to assess the quality of life suitable for ...
Xiaohui Zheng +4 more
doaj +2 more sources
Impact of COVID-19 pandemic on the health-related quality of life of frontline workers: the case of seven low-income Eastern African countries [PDF]
Purpose This study aimed to explore the potential impact of the COVID-19 pandemic on the health-related quality of life (HRQoL) of humanitarian and healthcare workers and its related factors in seven Eastern African countries (EAC).
Alexis Nizigiyimana +2 more
doaj +2 more sources
Minimal clinically important difference of EQ-5D-5L, SF-6Dv2, and QLU-C10D in hematologic malignancy patients in China [PDF]
Background To assess the minimum clinically important difference (MCID) of the EuroQol five-dimensional five-level (EQ-5D-5L), Short Form Six-Dimensional version 2 (SF-6Dv2), and Quality of Life Utility-Core 10 Dimensions (QLU-C10D) in Chinese patients ...
Fangyu Li +6 more
doaj +2 more sources

